Awarded a Grant from NEDO's Seed-stage Startup Support Program (NEDO STS)

We've been awarded grant "NEDO STS" from New Energy and Industrial Technology Development Organization(NEDO).

This grant was applied with the support of ANRI, a venture capital firm. Through this grant, xFOREST will accelerate the construction of an RNA-targeted drug discovery platform.

About ANRI

ANRI is a leading seed/early stage-focused investment firm based in Tokyo, Japan. ANRI is committed to helping exceptional founders build their next major companies. The firm invests in a wide range of disruptive ideas and technologies from consumer service to biotechnology. Founded in 2012, ANRI has funded more than 100 companies including hey, Mirrativ, LayerX, 10X and more.

• Click here for more information (link to external site)
• About NEDO
• About ANRI

About xFOREST Therapeutics

xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.